Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI

NeuroImage

Volumn 59, Issue 3, 2012, Pages 2670-2677

  Kitzler, Hagen H ^a   Su, Jason ^b   Zeineh, Michael ^b   Harper Little, Cynthia ^c   Leung, Andrew ^d   Kremenchutzky, Marcelo ^e   Deoni, Sean C ^f   Rutt, Brian K ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b STANFORD UNIVERSITY   (United States)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f Brown University   (United States)

Author keywords

Deficient MWF; Multiple sclerosis; Myelin water fraction; Normal appearing white matter; Quantitative relaxation MRI

Indexed keywords

MYELIN;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BRAIN ATROPHY; BRAIN MAPPING; BRAIN SIZE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; EXTENDED DISABILITY STATUS SCALE; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MULTICOMPONENT DRIVEN EQUILIBRIUM SINGLE PULSE OBSERVATION; MULTIPLE SCLEROSIS; MYELIN WATER FRACTION MAPPING; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; RATING SCALE; RISK FACTOR; THREE DIMENSIONAL IMAGING; WHITE MATTER;

ADULT; ALGORITHMS; ATROPHY; BRAIN MAPPING; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN SHEATH; WATER;

EID: 84855452907     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.08.052     Document Type: Article

References (56)

1. Ashburner J., Friston K.J. Unified segmentation. NeuroImage 2005, 26(3):839-851. Jul 1.
2. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed. 2002, 15(7-8):435-455. Nov-Dec.
3. Daumer M., Neuhaus A., Morrissey S., Hintzen R., Ebers G.C. MRI as an outcome in multiple sclerosis clinical trials. Neurology 2009, 72(8):705-711. Feb 24.
4. Deoni S.C. Transverse relaxation time (T2) mapping in the brain with off-resonance correction using phase-cycled steady-state free precession imaging. J. Magn. Reson. Imaging: JMRI 2009, 30(2):411-417. Aug.
5. Deoni S.C. Whole-brain Voxel-wise Analysis of Myelin Water Volume Fraction in Multiple Sclerosis Proceedings of the ISMRM 2009, 17:344.
6. Deoni S.C. Correction of main and transmit magnetic field (B0 and B1) inhomogeneity effects in multicomponent-driven equilibrium single-pulse observation of T1 and T2. Magn. Reson. Med.: off. j. Soc. Magn. Reson. Med./Soc. Magn. Reson. Med. 2011, 65(4):1021-1035. Apr.
7. Deoni S.C., Rutt B.K., Arun T., Pierpaoli C., Jones D.K. Gleaning multicomponent T1 and T2 information from steady-state imaging data. Magn. Reson. Med. 2008, 60(6):1372-1387. Dec.
8. Deoni S.C., Rutt B.K., Jones D.K. Investigating exchange and multicomponent relaxation in fully-balanced steady-state free precession imaging. J. Magn. Reson. Imaging. 2008, 27(6):1421-1429. Jun.
9. Dousset V., Brochet B., Vital A., Gross C., Benazzouz A., Boullerne A., et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am. J. Neuroradiol. 1995, 16(2):225-231. Feb.
10. Fazekas F., Barkhof F., Filippi M., Grossman R.I., Li D.K., McDonald W.I., et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 1999, 53(3):448-456. Aug 11.
11. Filippi M., Agosta F. Magnetization transfer MRI in multiple sclerosis. J. Neuroimaging. 2007, 17(Suppl. 1):22S-26S. Apr.
12. Fulton J.C., Grossman R.I., Udupa J., Mannon L.J., Grossman M., Wei L., et al. MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis. AJNR Am. J. Neuroradiol. 1999, 20(10):1951-1955. Nov-Dec.
13. Furby J., Hayton T., Anderson V., Altmann D., Brenner R., Chataway J., et al. Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis. Mult. Scler. 2008, 14(8):1068-1075. Sep.
14. Gareau P.J., Rutt B.K., Karlik S.J., Mitchell J.R. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J. Magn. Reson. Imaging. 2000, 11(6):586-595. Jun.
15. Held U., Heigenhauser L., Shang C., Kappos L., Polman C. Predictors of relapse rate in MS clinical trials. Neurology 2005, 65(11):1769-1773. Dec 13.
16. Horsfield M.A. Magnetization transfer imaging in multiple sclerosis. J. Neuroimaging. 2005, 15(4 Suppl.):58S-67S.
17. Kalkers N.F., Ameziane N., Bot J.C., Minneboo A., Polman C.H., Barkhof F. Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. Arch. Neurol. 2002, 59(10):1572-1576. Oct.
18. Karampekios S., Papanikolaou N., Papadaki E., Maris T., Uffman K., Spilioti M., et al. Quantification of magnetization transfer rate and native T1 relaxation time of the brain: correlation with magnetization transfer ratio measurements in patients with multiple sclerosis. Neuroradiology 2005, 47(3):189-196. Mar.
19. Kolind S.H., Deoni S.C. Rapid three-dimensional multicomponent relaxation imaging of the cervical spinal cord. Magn. reson. med.: off. j. Soc. Magn. Reson. Med./Soc. Magn. Reson. Med. 2011, 65(2):551-556. Feb.
20. Korteweg T., Rovaris M., Neacsu V., Filippi M., Comi G., Uitdehaag B.M., et al. Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?. Mult. Scler. 2009, 15(4):465-471. Apr.
21. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33(11):1444-1452. Nov.
22. Laule C., Vavasour I.M., Moore G.R., Oger J., Li D.K., Paty D.W., et al. Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study. J. Neurol. 2004, 25(3):284-293. Mar.
23. Laule C., Leung E., Lis D.K., Traboulsee A.L., Paty D.W., MacKay A.L., et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult. Scler. 2006, 12(6):747-753. Dec.
24. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47(6):707-717. Jun.
25. MacKay A.L., Vavasour I.M., Rauscher A., Kolind S.H., Madler B., Moore G.R., et al. MR relaxation in multiple sclerosis. Neuroimaging Clin N Am. 2009, 19(1):1-26. Feb.
26. Madler B., Drabycz S.A., Kolind S.H., Whittall K.P., MacKay A.L. Is diffusion anisotropy an accurate monitor of myelination? Correlation of multicomponent T2 relaxation and diffusion tensor anisotropy in human brain. Magn. Reson. Imaging 2008, 26(7):874-888. Sep.
27. Mallows C. Some comments on CP. Technometrics 1973, 15(4):661-675.
28. Martola J., Stawiarz L., Fredrikson S., Hillert J., Bergstrom J., Flodmark O., et al. Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease development. J. Neurol. Neurosurg. Psychiatry 2007, 78(4):375-380. Apr.
29. Martola J., Bergstrom J., Fredrikson S., Stawiarz L., Hillert J., Zhang Y., et al. A longitudinal observational study of brain atrophy rate reflecting four decades of multiple sclerosis: a comparison of serial 1D, 2D, and volumetric measurements from MRI images. Neuroradiology 2010, 52(2):109-117. Feb.
30. Mechelli A., Friston K.J., Frackowiak R.S., Price C.J. Structural covariance in the human cortex. J. Neurosci. 2005, 25(36):8303-8310. Sep 7.
31. Menon R.S., Allen P.S. Application of continuous relaxation time distributions to the fitting of data from model systems and excised tissue. Magn. Reson. Med. 1991, 20(2):214-227. Aug.
32. Meyers S.M., Laule C., Vavasour I.M., Kolind S.H., Madler B., Tam R., et al. Reproducibility of myelin water fraction analysis: a comparison of region of interest and voxel-based analysis methods. Magn. Reson. Imaging. 2009, 27(8):1096-1103. Oct.
33. Oh J., Han E.T., Pelletier D., Nelson S.J. Measurement of in vivo multi-component T2 relaxation times for brain tissue using multi-slice T2 prep at 1.5 and 3 T. Magn. Reson. Imaging. 2006, 24(1):33-43. Jan.
34. Oh J., Han E.T., Lee M.C., Nelson S.J., Pelletier D. Multislice brain myelin water fractions at 3T in multiple sclerosis. J. Neuroimaging. 2007, 17(2):156-163. Apr.
35. Oouchi H., Yamada K., Sakai K., Kizu O., Kubota T., Ito H., et al. Diffusion anisotropy measurement of brain white matter is affected by voxel size: underestimation occurs in areas with crossing fibers. AJNR Am. J. Neuroradiol. 2007, 28(6):1102-1106. Jun-Jul.
36. Papanikolaou N., Papadaki E., Karampekios S., Spilioti M., Maris T., Prassopoulos P., et al. T2 relaxation time analysis in patients with multiple sclerosis: correlation with magnetization transfer ratio. Eur. Radiol. 2004, 14(1):115-122. Jan.
37. Platten M., Ho P.P., Youssef S., Fontoura P., Garren H., Hur E.M., et al. Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 2005, 310(5749):850-855. Nov 4.
38. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58(6):840-846. Dec.
39. Rudick R.A., Fisher E., Lee J.C., Simon J., Jacobs L. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999, 53(8):1698-1704. Nov 10.
40. Rudick R.A., Lee J.C., Nakamura K., Fisher E. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. J. Neurol. Sci. 2009, 282(1-2):106-111. Jul 15.
41. Schmierer K., Wheeler-Kingshott C.A., Boulby P.A., Scaravilli F., Altmann D.R., Barker G.J., et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. NeuroImage 2007, 35(2):467-477. Apr 1.
42. Seewann A., Vrenken H., van der Valk P., Blezer E.L., Knol D.L., Castelijns J.A., et al. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch. Neurol. 2009, 66(5):601-609. May.
43. Smith S., Jenkinson M. FSLUTILS http://wwwfmriboxacuk/fsl/avwutils/indexhtml.
44. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004, 23(Suppl. 1):S208-S219.
45. Song S.K., Sun S.W., Ju W.K., Lin S.J., Cross A.H., Neufeld A.H. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. NeuroImage 2003, 20(3):1714-1722. Nov.
46. Sormani M.P., Bruzzi P., Beckmann K., Wagner K., Miller D.H., Kappos L., et al. MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN beta-1b. Neurology 2003, 60(9):1462-1466. May 13.
47. van Waesberghe J.H., Kamphorst W., De Groot C.J., van Walderveen M.A., Castelijns J.A., Ravid R., et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann. Neurol. 1999, 46(5):747-754. Nov.
48. Vavasour I.M., Whittall K.P., MacKay A.L., Li D.K., Vorobeychik G., Paty D.W. A comparison between magnetization transfer ratios and myelin water percentages in normals and multiple sclerosis patients. Magn. Reson. Med. 1998, 40(5):763-768. Nov.
49. Vavasour I.M., Clark C.M., Li D.K., Mackay A.L. Reproducibility and reliability of MR measurements in white matter: clinical implications. NeuroImage 2006, 32(2):637-642. Aug 15.
50. Vellinga M.M., Geurts J.J., Rostrup E., Uitdehaag B.M., Polman C.H., Barkhof F., et al. Clinical correlations of brain lesion distribution in multiple sclerosis. J. Magn. Reson. Imaging. 2009, 29(4):768-773. Apr.
51. Vrenken H., Seewann A., Knol D.L., Polman C.H., Barkhof F., Geurts J.J. Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types. AJNR Am. J. Neuroradiol. 2010, 31(3):541-548. Mar.
52. Webb S., Munro C.A., Midha R., Stanisz G.J. Is multicomponent T2 a good measure of myelin content in peripheral nerve?. Magn. Reson. Med. 2003, 49(4):638-645. Apr.
53. Weiner H.L. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?. Ann. Neurol. 2009, 65(3):239-248. Mar.
54. Whittall K.P., MacKay A.L., Graeb D.A., Nugent R.A., Li D.K., Paty D.W. In vivo measurement of T2 distributions and water contents in normal human brain. Magn. Reson. Med. 1997, 37(1):34-43. Jan.
55. Yushkevich P.A., Piven J., Hazlett H.C., Smith R.G., Ho S., Gee J.C., et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. NeuroImage 2006, 31(3):1116-1128. Jul 1.
56. Zivadinov R. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials. Methods Find. Exp. Clin. Pharmacol. 2009, 31(1):29-40. Jan-Feb.